Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 30, Issue 5, Pages 869-877Publisher
WILEY
DOI: 10.1002/jbmr.2418
Keywords
OSTEOCLAST; MOLECULAR PATHWAYS; CYTOKINES; CELL; TISSUE SIGNALING; TRANSCRIPTION FACTORS
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- Grants-in-Aid for Scientific Research [25670188, 25118709, 26253075] Funding Source: KAKEN
Ask authors/readers for more resources
We have previously reported that transforming growth factor (TGF-) plays an essential role in receptor activator of nuclear factor-B ligand (RANKL)-induced osteoclastogenesis. However, the detailed underlying molecular mechanisms still remain unclear. Formaldehyde-assisted isolation of regulatory elements (FAIRE) and chromatin immunoprecipitation (ChIP) followed by sequencing (FAIRE-seq and ChIP-seq) analyses indicated the cooperation of Smad2/3 with c-Fos during osteoclastogenesis. Biochemical analysis and immunocytochemical analysis revealed that physical interaction between Smad2/3 and c-Fos is required for their nuclear translocation. The gene expression of nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1), a key regulator of osteoclastogenesis, was regulated by RANKL and TGF-, and c-Fos binding to open chromatin sites was suppressed by inhibition of TGF- signaling by SB431542. Conversely, Smad2/3 binding to Nfatc1 was impaired by c-Fos deficiency. These results suggest that TGF- regulates RANKL-induced osteoclastogenesis through reciprocal cooperation between Smad2/3 and c-Fos. (c) 2014 American Society for Bone and Mineral Research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available